F. Maurier

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

Christian Pagnoux, Alexandre Karras, C. Khouatra et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

Cloé Comarmond, Christian Pagnoux, Mehdi Khellaf et al. · Arthritis & Rheumatism · 2012 · 915 citations

Life Sciences, Internal Medicine, Autoimmunity +13

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

K. Mariampillai, Benjamin Granger, Damien Amelin et al. · JAMA Neurology · 2018 · 437 citations · Full text

Medicine, Immunology, Internal Medicine +15

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Pierre Charles, Benjamin Terrier, Élodie Perrodeau et al. · Annals of the Rheumatic Diseases · 2018 · 336 citations

Life Sciences, Immunology, Pharmacotherapy +15

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14